The α-synuclein seed amplification assay was studied in 1123 participants in the Parkinson’s Progression Markers Initiative, showing excellent diagnostic performance in distinguishing PD from healthy controls, with 87.7% sensitivity for PD and 96.3% specificity for healthy controls [54]. Here, SNCA is linked to Parkinson disease.